High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial.
Saved in:
| Title: | High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial. |
|---|---|
| Authors: | Patel RR; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Albany Medical College, Albany, USA., He K; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Departments of Radiation Oncology, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, China., Barsoumian HB; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Chang JY; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Tang C; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Verma V; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Comeaux N; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Chun SG; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Gandhi S; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Truong MT; Departments of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, USA., Erasmus JJ; Departments of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, USA., Hong DS; Departments of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA., Lee PP; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Ning MS; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Nguyen QN; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Heymach JV; Departments of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Altan M; Departments of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Blumenschein G; Departments of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Fossella FV; Departments of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Sezen D; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of Radiation Oncology, School of Medicine, Koc University, Istanbul, Turkey., Chen D; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA; Albany Medical College, Albany, USA., Carter BW; Departments of Thoracic Imaging, The University of Texas MD Anderson Cancer Center, Houston, USA., Davies MA; Departments of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Glitza IC; Departments of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Diab A; Departments of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Ferrarotto R; Departments of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Cabanillas ME; Departments of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, USA., Yuan Y; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, USA., Shah SJ; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Parra ER; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Sun B; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Cortez MA; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Welsh JW; Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: jwelsh@mdanderson.org. |
| Source: | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2021 Sep; Vol. 162, pp. 60-67. Date of Electronic Publication: 2021 Jul 05. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
